转自：证券时报 人民财讯10月28日电，奕瑞科技(688301)10月28日发布2025年三季报，公司第三季度营业收入4.82亿 元，同比增长46.18%；净利润1.36亿元，同比增长64.43%。2025年前三季度营业收入15.49亿元，同比 增长14.22%；净利润4.71亿元，同比增长20.61%；基本每股收益2.35元。第三季度业绩增长主要系系统 方案、核心部件业务以及探测器业务较去年同期有较大增长所致。 ...

以下文章来源于中关村融智特种机器人产业联盟 ，作者小盟 整合机器人产业技术和人才资源 中关村融智特种机器人产业联盟 . 添加客服微信： myrobotics ，备注" 参会人员 "，邀请进入会议群。 缴费成功后请务必将 参会回执 发送邮件至编辑部邮箱（ cims_journal@qq.com ） 点击蓝字下载参会回执文件： 附件：参会回执.docx 各相关单位： 为引领行业健康发展，充分发挥团体标准在特种机器人产业发展中的技术支撑作用，根据中关村融 智特种机器人产业联盟团体标准工作安排，现开展团体标准立项征集工作。 具体事项通知如下： 征集范围 征集的重点项目领域为机器人及智能装备相关领域，包括但不限于特殊环境应用机器人及关键技术、核 心部件等相关标准。 申报要求 1、申请立项标准应符合国家相关法律法规的要求，不得与国家有关产业政策相抵触，与现行国家 标准、行业标准、地方标准等无交叉和重复，技术要求不低于现行国家标准及行业标准的相关技术要 求。 2、应以促进技术进步、提高行业竞争力、满足市场发展需求为目标，所涉技术具有明显或显著创 新，具有可行性、实用性和广泛代表性。鼓励相关单位采取产学研合作形式联合申请，广 ...

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [6][12]. Core Insights - The company achieved a revenue of 1.067 billion yuan in H1 2025, representing a year-on-year increase of 3.94%, and a net profit attributable to shareholders of 335 million yuan, up 8.82% year-on-year [1]. - The company's gross margin was 52.97%, with a slight year-on-year decrease of 1.18 percentage points, while the net profit margin improved by 1.20 percentage points to 30.47% [2]. - The company is expected to benefit from the medical equipment upgrade policy, with projected revenues of 2.29 billion, 3.02 billion, and 3.83 billion yuan for 2025, 2026, and 2027 respectively, alongside net profits of 627 million, 851 million, and 1.053 billion yuan [4]. Financial Performance Summary - In H1 2025, the company's revenue from the detector business was 866 million yuan, a year-on-year increase of 2.65%, while the core components business generated 82 million yuan in revenue with a gross margin of 18.2% [2]. - The company invested 154 million yuan in R&D in H1 2025, representing a R&D expense ratio of 14.46% [2]. - The company forecasts a net profit growth rate of 34.9% for 2025, with an expected PE ratio of 34 [5][10].

Core Insights - The company experienced a decline in its main detector business due to weak industry demand, but new products showed significant growth [1] - The overall gross margin decreased, coupled with increased management and financial expenses, leading to a drop in net profit margin [2] - The company is optimistic about a turnaround in performance for the full year 2025, supported by improved market conditions and contract liabilities growth [3] - The company is pursuing vertical integration and horizontal expansion to establish itself as a comprehensive component supplier [4] - The company plans to raise funds through a private placement to support the construction of X-ray vacuum devices and comprehensive solutions, which will enhance production capacity [5] Financial Performance - In 2024, the company achieved total revenue of 1.831 billion yuan, a year-on-year decrease of 1.74%, with the detector business revenue at 1.490 billion yuan, down 11.99% [1] - The overall gross margin for 2024 was approximately 50.11%, a decline of 7.73 percentage points year-on-year, with the detector gross margin at 56.65%, down 3.48 percentage points [2] - The net profit for 2024 was 465 million yuan, a year-on-year decline of 23.43%, resulting in a net profit margin of 25.40%, down 7.19 percentage points [2] Business Development - The company is actively developing upstream components and materials for detectors, with successful R&D and production of 2D collimators for medical CT and security CT applications [4] - The company has completed the R&D and initial production of high-voltage generators and combination ray sources, with plans for further expansion into more application areas [4] - The company aims to increase production capacity by 77,000 tubes and 19,300 sets of X-ray comprehensive solutions through a planned investment project [5] Future Outlook - The company expects revenue growth to reach 2.208 billion yuan in 2025, with net profit projected at 648 million yuan, indicating a potential performance reversal [5] - The company maintains a positive long-term growth outlook, supported by ongoing market recovery and expansion initiatives [5]